These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37670344)

  • 21. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018.
    Dang K; Wang X; Hu J; Zhang Y; Cheng L; Qi X; Liu L; Ming Z; Tao X; Li Y
    Cardiovasc Diabetol; 2024 Jan; 23(1):8. PubMed ID: 38184598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study.
    Li H; Zuo Y; Qian F; Chen S; Tian X; Wang P; Li X; Guo X; Wu S; Wang A
    Cardiovasc Diabetol; 2022 Jun; 21(1):105. PubMed ID: 35689232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between triglyceride glucose-body mass and one-year all-cause mortality of patients with heart failure: a retrospective study utilizing the MIMIC-IV database.
    Dou J; Guo C; Wang Y; Peng Z; Wu R; Li Q; Zhao H; Song S; Sun X; Wei J
    Cardiovasc Diabetol; 2023 Nov; 22(1):309. PubMed ID: 37940979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk.
    Cai XL; Xiang YF; Chen XF; Lin XQ; Lin BT; Zhou GY; Yu L; Guo YS; Lin KY
    Cardiovasc Diabetol; 2023 Aug; 22(1):198. PubMed ID: 37537553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between Triglyceride-Glucose Index and risk of all-cause and cardiovascular mortality in adults with prior cardiovascular disease: a cohort study using data from the US National Health and Nutrition Examination Survey, 2007-2018.
    Hu B; Wang Y; Wang Y; Feng J; Fan Y; Hou L
    BMJ Open; 2024 Jul; 14(7):e084549. PubMed ID: 38969366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prospective cohort study of the association of cardiovascular disease with triglyceride glucose index and triglyceride glucose-related indicators].
    Wang SL; Zhang XH; Mulati B; Guo H; He J; Re M; Wang XP; Ma RL; Guo SX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Dec; 44(12):1943-1949. PubMed ID: 38155096
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study.
    Barzegar N; Tohidi M; Hasheminia M; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2020 Sep; 19(1):155. PubMed ID: 32993633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study.
    Moon JH; Kim Y; Oh TJ; Moon JH; Kwak SH; Park KS; Jang HC; Choi SH; Cho NH
    Endocrinol Metab (Seoul); 2023 Aug; 38(4):406-417. PubMed ID: 37533176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-linear association of triglyceride-glucose index with cardiovascular and all-cause mortality in T2DM patients with diabetic kidney disease: NHANES 2001-2018 retrospective cohort study.
    Zhang H; Wang L; Zhang Q; Song Y; Cai M; Bao J; Yu Q
    Lipids Health Dis; 2024 Aug; 23(1):253. PubMed ID: 39154178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study from MIMIC-IV database.
    Hu Y; Zhao Y; Zhang J; Li C
    Cardiovasc Diabetol; 2024 Feb; 23(1):64. PubMed ID: 38341579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan Cohort Study (ICS).
    Rafiee H; Mohammadifard N; Nouri F; Alavi Tabatabaei G; Najafian J; Sadeghi M; Boshtam M; Roohafza H; Haghighatdoost F; Hassannejad R; Sarrafzadegan N
    Eur J Med Res; 2024 Feb; 29(1):135. PubMed ID: 38368388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis.
    Li S; Guo B; Chen H; Shi Z; Li Y; Tian Q; Shi S
    Sci Rep; 2019 May; 9(1):7320. PubMed ID: 31086234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the baseline insulin resistance surrogates and their longitudinal trajectories on cardiovascular disease (coronary heart disease and stroke): a prospective cohort study in rural China.
    Wang S; Zhang X; Keerman M; Guo H; He J; Maimaitijiang R; Wang X; Ma R; Guo S
    Front Endocrinol (Lausanne); 2023; 14():1259062. PubMed ID: 38189050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study.
    Cheng Y; Fang Z; Zhang X; Wen Y; Lu J; He S; Xu B
    Cardiovasc Diabetol; 2023 Mar; 22(1):75. PubMed ID: 36997935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between triglyceride-glucose index and risk of incident diabetes: a secondary analysis based on a Chinese cohort study : TyG index and incident diabetes.
    Li X; Li G; Cheng T; Liu J; Song G; Ma H
    Lipids Health Dis; 2020 Nov; 19(1):236. PubMed ID: 33161902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes.
    Liu C; Liang D; Xiao K; Xie L
    Cardiovasc Diabetol; 2024 May; 23(1):171. PubMed ID: 38755682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time course of the triglyceride glucose index accumulation with the risk of cardiovascular disease and all-cause mortality.
    Tian X; Chen S; Zhang Y; Zhang X; Xu Q; Wang P; Wu S; Wang A; Luo Y
    Cardiovasc Diabetol; 2022 Sep; 21(1):183. PubMed ID: 36100896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension.
    Liu Y; Zhu B; Zhou W; Du Y; Qi D; Wang C; Cheng Q; Zhang Y; Wang S; Gao C
    Cardiovasc Diabetol; 2023 Jun; 22(1):133. PubMed ID: 37296406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-based or non-insulin-based insulin resistance indicators and risk of long-term cardiovascular and all-cause mortality in the general population: A 25-year cohort study.
    Lin Z; Yuan S; Li B; Guan J; He J; Song C; Li J; Dou K
    Diabetes Metab; 2024 Sep; 50(5):101566. PubMed ID: 39127168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study.
    Zhang Z; Zhao L; Lu Y; Meng X; Zhou X
    Cardiovasc Diabetol; 2023 Jun; 22(1):161. PubMed ID: 37386494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.